Recital 5, Commission Regulation (EC) No 2037/2005 of 14 December 2005 amending the conditions for…

In forcesince 14 Dec 2005

The opinion of the Authority concludes that the use of the new formulation would not be expected to introduce any additional risks or concerns for human, animal and environmental safety and that the new formulation does not adversely influence the stability of lasalocid A sodium.